Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis

Abstract

The soluble cluster of differentiation 14 (or presepsin) is a free fragment of glycoprotein expressed on monocytes and macrophages. Although many studies have been conducted recently, the diagnostic performance of presepsin for sepsis remains debated. We performed a systematic review and meta-analysis of the available literature to assess the accuracy of presepsin for the diagnosis of sepsis in adult patients and compared the performance between presepsin, C-reactive protein (CRP), and procalcitonin (PCT). A comprehensive systemic search was conducted in PubMed, EMBASE, and Google Scholar for studies that evaluated the diagnostic accuracy of presepsin for sepsis until January 2017. The hierarchical summary receiver operating characteristic method was used to pool individual sensitivity, specificity, diagnostic odds ratio (DOR), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and area under the receiver operating characteristic curve (AUC). Eighteen studies, comprising 3470 patients, met our inclusion criteria. The pooled diagnosis sensitivity and specificity of presepsin for sepsis were 0.84 (95% CI 0.80–0.87) and 0.76 (95% CI 0.67–0.82), respectively. Furthermore, the pooled DOR, PLR, NLR, and AUC were 16 (95% CI 10–25), 3.4 (95% CI 2.5–4.6), 0.22 (95% CI 0.17–0.27), and 0.88 (95% CI 0.85–0.90), respectively. Significant heterogeneity was found in both sensitivities (Cochrane Q = 137.43, p < 0.001, I 2 = 87.63%) and specificities (Cochrane Q = 180.76, p < 0.001, I 2 = 90.60%). Additionally, we found no significant difference between presepsin and PCT (AUC 0.87 vs. 0.86) or CRP (AUC 0.85 vs. 0.85). However, for studies conducted in ICU, the pooled sensitivity of presepsin was found to be higher than PCT (0.88, 95% CI 0.82–0.92 vs. 0.75, 95% CI 0.68–0.81), while the pooled specificity of presepsin was lower than PCT (0.58, 95% CI 0.42–0.73 vs. 0.75, 95% CI 0.65–0.83). Based on the results of our meta-analysis, presepsin is a promising marker for diagnosis of sepsis as PCT or CRP, but its results should be interpreted more carefully and cautiously since too few studies were included and those studies had high heterogeneity between them. In addition, continuing re-evaluation during the course of sepsis is advisable.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 53

1. 1.

   Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16-19.

   Not in our library10.5847/wjem.j.issn.1920-8642.2014.01.002

2. 2.

   Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351(1–2):17-29.

   Not in our library10.1016/j.cccn.2004.08.018

3. 3.

   Chen KF, Chaou CH, Jiang JY, Yu HW, Meng YH, Tang WC, Wu CC. Diagnostic accuracy of lipopolysaccharide-binding protein as biomarker for sepsis in adult patients: a systematic review and meta-analysis. PLoS ONE. 2016;11(4):e0153188.

   Not in our library10.1371/journal.pone.0153188

4. 4.

   Guignant C, Voirin N, Venet F, Poitevin F, Malcus C, Bohe J, Lepape A, Monneret G. Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients. Intensive Care Med. 2009;35(11):1859-1867.

   Not in our library10.1007/s00134-009-1610-5

5. 5.

   Lu YH, Liu L, Qiu XH, Yu Q, Yang Y, Qiu HB. Effect of early goal directed therapy on tissue perfusion in patients with septic shock. World J Emerg Med. 2013;4(2):117-122.

   Not in our library10.5847/wjem.j.issn.1920-8642.2013.02.006

6. 6.

   Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia. Intensive Care Med. 2008;34(11):2084-2091.

   Not in our library10.1007/s00134-008-1173-x

7. 7.

   Wu HP, Chen CK, Chung K, Jiang BY, Yu TJ, Chuang DY. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity. J Formos Med Assoc. 2009;108(1):20-27.

   Not in our library10.1016/s0929-6646(09)60028-0

8. 8.

   Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486-552.

   Not in our library10.1097/ccm.0000000000002255

9. 9.

   Julian-Jimenez A, Candel-Gonzalez FJ, Gonzalez Del Castillo J. Usefulness of inflammation and infection biomarkers in the Emergency Department. Enferm Infecc Microbiol Clin. 2014;32(3):177-190.

   Not in our library10.1016/j.eimc.2013.01.005

10. 10.

    Kibe S, Adams K, Barlow G. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011;66(Suppl 2):ii33-ii40.

    Not in our library10.1093/jac/dkq523

11. 11.

    Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis. 2007;7(3):210-217.

    Not in our library10.1016/s1473-3099(07)70052-x

12. 12.

    Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426-435.

    Not in our library10.1016/s1473-3099(12)70323-7

13. 13.

    Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001;38(2–3):189-197.

    Not in our library10.1016/s0161-5890(01)00042-6

14. 14.

    Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta. 2011;412(23–24):2157-2161.

    Not in our library10.1016/j.cca.2011.07.024

15. 15.

    Gong XW, Jiang Y. Structure, function and modulation of actin-related protein 2/3 complex. Sheng Li Ke Xue Jin Zhan. 2004;35(4):306-310.

    Not in our library

16. 16.

    Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med. 2011;24(Suppl 2):12-14.

    Not in our library10.3109/14767058.2011.601923

17. 17.

    Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemother. 2011;17(6):764-769.

    Not in our library10.1007/s10156-011-0254-x

18. 18.

    Shirakawa K, Naitou K, Hirose J, Takahashi T, Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin Chem Lab Med. 2011;49(5):937-939.

    Not in our library10.1515/cclm.2011.145

19. 19.

    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006-1012.

    Not in our library10.1016/j.jclinepi.2009.06.005

20. 20.

    Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.

    Not in our library10.2307/2529310

21. 21.

    Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. Group Q-: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-536.

    Not in our library10.7326/0003-4819-155-8-201110180-00009

22. 22.

    Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865-2884.

    Not in our library10.1002/sim.942

23. 23.

    Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12(14):1293-1316.

    Not in our library10.1002/sim.4780121403

24. 24.

    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.

    Not in our library10.1002/sim.1186

25. 25.
    Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment · 2014

    No notice
26. 26.

    Brenner T, Fleming T, Uhle F, Silaff S, Schmitt F, Salgado E, Ulrich A, Zimmermann S, Bruckner T, Martin E, et al. Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study. Crit Care. 2014;18(6):683.

    Not in our library10.1186/s13054-014-0683-x

27. 27.

    Cakir Madenci O, Yakupoglu S, Benzonana N, Yucel N, Akbaba D, Orcun Kaptanagasi A. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns. 2014;40(4):664-669.

    Not in our library10.1016/j.burns.2013.08.024

28. 28.

    Carpio R, Zapata J, Spanuth E, Hess G. Utility of presepsin (sCD14-ST) as a diagnostic and prognostic marker of sepsis in the emergency department. Clin Chim Acta. 2015;450:169-175.

    Not in our library10.1016/j.cca.2015.08.013

29. 29.

    Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, Nishida T, Irie Y, Miura M, Iguchi H, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother. 2012;18(6):891-897.

    Not in our library10.1007/s10156-012-0435-2

30. 30.

    Godnic M, Stubljar D, Skvarc M, Jukic T. Diagnostic and prognostic value of sCD14-ST–presepsin for patients admitted to hospital intensive care unit (ICU). Wien Klin Wochenschr. 2015;127(13–14):521-527.

    Not in our library10.1007/s00508-015-0719-5

31. 31.

    Ishikura H, Nishida T, Murai A, Nakamura Y, Irie Y, Tanaka J, Umemura T. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Crit Care. 2014;18(1):R19.

    Not in our library10.1186/cc13700

32. 32.

    Kweon OJ, Choi JH, Park SK, Park AJ. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. J Crit Care. 2014;29(6):965-970.

    Not in our library10.1016/j.jcrc.2014.06.014

33. 33.
    Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department · 2013

    No notice
34. 34.

    Nakamura Y, Ishikura H, Nishida T, Kawano Y, Yuge R, Ichiki R, Murai A. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiol. 2014;14:88.

    Not in our library10.1186/1471-2253-14-88

35. 35.

    Romualdo LG, Torrella PE, Gonzalez MV, Sanchez RJ, Holgado AH, Freire AO, Acebes SR, Oton MD. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin Biochem. 2014;47(7–8):505-508.

    Not in our library10.1016/j.clinbiochem.2014.02.011

36. 36.

    Sargentini V, Ceccarelli G, D’Alessandro M, Collepardo D, Morelli A, D’Egidio A, Mariotti S, Nicoletti AM, Evangelista B, D’Ettorre G, et al. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study. Clin Chem Lab Med. 2015;53(4):567-573.

    Not in our library10.1515/cclm-2014-0119

37. 37.

    Takahashi G, Shibata S, Ishikura H, Miura M, Fukui Y, Inoue Y, Endo S. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study. Eur J Anaesthesiol. 2015;32(3):199-206.

    Not in our library10.1097/eja.0000000000000178

38. 38.
    Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study · 2013

    No notice
39. 39.

    Vodnik T, Kaljevic G, Tadic T, Majkic-Singh N. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clin Chem Lab Med. 2013;51(10):2053-2062.

    Not in our library10.1515/cclm-2013-0061

40. 40.

    de Guadiana Romualdo LG, Torrella PE, Acebes SR, Oton MD, Sanchez RJ, Holgado AH, Santos EJ, Freire AO. Diagnostic accuracy of presepsin (sCD14-ST) as a biomarker of infection and sepsis in the emergency department. Clin Chim Acta. 2016;464:6-11.

    Not in our library10.1016/j.cca.2016.11.003

Cited by papers we hold 2

• The Pathogenesis of Sepsis and Potential Therapeutic Targets · 2019
  No notice
• The role of presepsin in the diagnosis and assessment of severity of sepsis and severe pneumonia · 2018
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.